Literature DB >> 18605750

Discovering oxysterols in plasma: a window on the metabolome.

William J Griffiths1, Martin Hornshaw, Gary Woffendin, Sharon F Baker, Andrew Lockhart, Sibylle Heidelberger, Magnus Gustafsson, Jan Sjövall, Yuqin Wang.   

Abstract

While the proteome defines the expressed gene products, the metabolome results from reactions controlled by such gene products. Plasma represents an accessible "window" to the metabolome both in regard of availability and content. The wide range of the plasma metabolome, in terms of molecular diversity and abundance, makes its comprehensive analysis challenging. Here we demonstrate an analytical method designed to target one region of the metabolome, that is, oxysterols. Since the discovery of their biological activity as ligands to nuclear receptors there has been a reawakening of interest in oxysterols and their analysis. In addition, the oxysterols, 24S- and 27-hydroxycholesterol, are currently under investigation as potential biomarkers associated with neurodegenerative disorders such as Alzheimer's disease and multiple sclerosis; widespread analysis of these lipids in clinical studies will require the development of robust, sensitive and rapid analytical techniques. In this communication we present results of an investigation of the oxysterols content of human plasma using a newly developed high-performance liquid chromatography-mass spectrometry (HPLC-MS) method incorporating charge-tagging and high-resolution MS. The method has allowed the identification in plasma of monohydroxylated cholesterol molecules, 7alpha-, 24S-, and 27-hydroxycholesterol; the cholestenetriol 7alpha,27-dihydroxycholesterol; and 3beta-hydroxycholest-5-en-27-oic acid and its metabolite 3beta,7alpha-dihydroxycholest-5-en-27-oic acid. The methodology described is also applicable for the analysis of other sterols in plasma, that is, cholesterol, 7-dehydrocholesterol, and desmosterol, as well as cholesterol 5,6- seco-sterols and steroid hormones. Although involving derivatization, sample preparation is straightforward and chromatographic analysis rapid (17 min), while the MS method offers high sensitivity (ng/mL of sterol in plasma, or pg on-column) and specificity. The methodology is suitable for targeted metabolomic analysis of sterols, oxysterols, and steroid hormones opening a "window" to view this region of the metabolome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18605750      PMCID: PMC2567817          DOI: 10.1021/pr8001639

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  56 in total

1.  Electrospray and atmospheric pressure chemical ionization tandem mass spectrometric behavior of eight anabolic steroid glucuronides.

Authors:  T Kuuranne; M Vahermo; A Leinonen; R Kostianen
Journal:  J Am Soc Mass Spectrom       Date:  2000-08       Impact factor: 3.109

Review 2.  Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples.

Authors:  Xianlin Han; Richard W Gross
Journal:  Mass Spectrom Rev       Date:  2005 May-Jun       Impact factor: 10.946

3.  Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics.

Authors:  Anders Nordström; Elizabeth Want; Trent Northen; Janne Lehtiö; Gary Siuzdak
Journal:  Anal Chem       Date:  2007-12-18       Impact factor: 6.986

Review 4.  Two 7 alpha-hydroxylase enzymes in bile acid biosynthesis.

Authors:  M Schwarz; E G Lund; D W Russell
Journal:  Curr Opin Lipidol       Date:  1998-04       Impact factor: 4.776

5.  Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation.

Authors:  K Rose; A Allan; S Gauldie; G Stapleton; L Dobbie; K Dott; C Martin; L Wang; E Hedlund; J R Seckl; J A Gustafsson; R Lathe
Journal:  J Biol Chem       Date:  2001-04-04       Impact factor: 5.157

6.  Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.

Authors:  N Tagawa; J Tamanaka; A Fujinami; Y Kobayashi; T Takano; S Fukata; K Kuma; H Tada; N Amino
Journal:  Clin Chem       Date:  2000-04       Impact factor: 8.327

7.  7 alpha-hydroxylation of 26-hydroxycholesterol, 3 beta-hydroxy-5-cholestenoic acid and 3 beta-hydroxy-5-cholenoic acid by cytochrome P-450 in pig liver microsomes.

Authors:  A Toll; J Shoda; M Axelson; J Sjövall; K Wikvall
Journal:  FEBS Lett       Date:  1992-01-13       Impact factor: 4.124

8.  Formation of 7 alpha- and 7 beta-hydroxylated bile acid precursors from 27-hydroxycholesterol in human liver microsomes and mitochondria.

Authors:  J Shoda; A Toll; M Axelson; F Pieper; K Wikvall; J Sjövall
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

9.  Determination of dehydroepiandrosterone sulphate in biological samples by liquid chromatography/atmospheric pressure chemical ionization-mass spectrometry using [7,7,16,16-2H4]-dehydroepiandrosterone sulphate as an internal standard.

Authors:  M Nakajima; S Yamato; K Shimada
Journal:  Biomed Chromatogr       Date:  1998 Jul-Aug       Impact factor: 1.902

10.  Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols.

Authors:  Kersti Karu; Martin Hornshaw; Gary Woffendin; Karl Bodin; Mats Hamberg; Gunvor Alvelius; Jan Sjövall; John Turton; Yuqin Wang; William J Griffiths
Journal:  J Lipid Res       Date:  2007-01-24       Impact factor: 5.922

View more
  23 in total

1.  A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma.

Authors:  Jeffrey G McDonald; Daniel D Smith; Ashlee R Stiles; David W Russell
Journal:  J Lipid Res       Date:  2012-04-19       Impact factor: 5.922

2.  Are 15-oxygenated sterols present in the human circulation?

Authors:  William J Griffiths; Yuqin Wang
Journal:  J Lipid Res       Date:  2010-10-18       Impact factor: 5.922

Review 3.  Metabolomics: moving to the clinic.

Authors:  Anders Nordström; Rolf Lewensohn
Journal:  J Neuroimmune Pharmacol       Date:  2009-04-28       Impact factor: 4.147

Review 4.  Recommendations on the Development of a Bioanalytical Assay for 4β-Hydroxycholesterol, an Emerging Endogenous Biomarker of CYP3A Activity.

Authors:  Anne-Françoise Aubry; Brian Dean; Ulf Diczfalusy; Angela Goodenough; André Iffland; James McLeod; Naidong Weng; Ziping Yang
Journal:  AAPS J       Date:  2016-06-27       Impact factor: 4.009

5.  Detecting oxysterols in the human circulation.

Authors:  Ingemar Björkhem; Ulf Diczfalusy; Tomas Olsson; David W Russell; Jeffery G McDonald; Yuqin Wang; William J Griffiths
Journal:  Nat Immunol       Date:  2011-06-20       Impact factor: 25.606

6.  Chemical Isotope Labeling LC-MS for Metabolomics.

Authors:  Shuang Zhao; Liang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Cerebrospinal fluid steroidomics: are bioactive bile acids present in brain?

Authors:  Michael Ogundare; Spyridon Theofilopoulos; Andrew Lockhart; Leslie J Hall; Ernest Arenas; Jan Sjövall; A Gareth Brenton; Yuqin Wang; William J Griffiths
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

Review 8.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

9.  Phosphonium labeling for increasing metabolomic coverage of neutral lipids using electrospray ionization mass spectrometry.

Authors:  Hin-Koon Woo; Eden P Go; Linh Hoang; Sunia A Trauger; Benjamin Bowen; Gary Siuzdak; Trent R Northen
Journal:  Rapid Commun Mass Spectrom       Date:  2009-06       Impact factor: 2.419

10.  Targeted lipidomic analysis of oxysterols in the embryonic central nervous system.

Authors:  Yuqin Wang; Kyle M Sousa; Karl Bodin; Spyridon Theofilopoulos; Paola Sacchetti; Martin Hornshaw; Gary Woffendin; Kersti Karu; Jan Sjövall; Ernest Arenas; William J Griffiths
Journal:  Mol Biosyst       Date:  2009-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.